Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219881 · ClinicalTrials.gov registry record · Phase 3

Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery

A Phase 3 study, sponsored by Ohio State University.

Completed
Registry status
Phase 3
Development phase
75
Enrollment target

NCT01219881: Completed Phase 3 study, sponsored by Ohio State University.

NCT01219881 is a Phase 3 study that has completed, run by Ohio State University. The registered enrollment target is 75 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219881, a Phase 3 study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
Phase 3
Development phase
75 participants
Enrollment target

Study Summary

This is a single-center, prospective, randomized, double-blind, double-arm trial including 68 subjects scheduled to undergo urological cystoscope surgeries under general anesthesia (GA) with intubation through a laryngeal mask airway (LMA) at The Ohio State University Medical Center (OSUMC). Double blinding will be based on both the subject and the research staff being unaware of which trial arm the subject is randomized into. Eligible subjects that provide voluntary and written informed consent will be included in this study.

Primary Outcome

Recovery Time after exposure to desflurane or sevoflurane considering time of emergence from anesthesia

Interventions

  • DRUG Sevoflurane
  • DRUG Desflurane

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2010-09
Est. Completion 2012-10
Phase Phase 3
Ohio State University

552 total trials

What the finished NCT01219881 record still lists

NCT01219881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.

NCT01219881 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01219881 about?

NCT01219881 is a clinical study titled "Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery". This is a single-center, prospective, randomized, double-blind, double-arm trial including 68 subjects scheduled to undergo urological cystoscope surgeries under general anesthesia (GA) with intubation through a laryngeal mask airway (LMA) at The Ohio State University Medical Center (OSUMC). Double ...

What is the current status of trial NCT01219881?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2010-09. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01219881?

The interventions under investigation include: Sevoflurane (DRUG), Desflurane (DRUG).

Who is sponsoring clinical trial NCT01219881?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01219881's enrollment target sits among peer trials

75 1773rd of 2000 higher than 221 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01219881, the US trial registry maintained by the National Library of Medicine. NCT01219881 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.